Atebimetinib Clinical Trials (2026): 1 Studies for Pancreatic Adenocarcinoma & Pancreatic Adenocarcinoma Metastatic
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 Atebimetinib clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Pancreatic Adenocarcinoma & Pancreatic Adenocarcinoma Metastatic) and 510 total planned enrollment. 1 Phase 3 Atebimetinib trial are listed. 1 Atebimetinib clinical trial is actively recruiting at 15 U.S. sites across 13 states. Most recent activity: NCT07562152 (Feb 2029).
Where to Participate: All Atebimetinib Trial Sites in the U.S. (15 sites across 13 states)
Every actively recruiting Atebimetinibtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| AZ | City of Hope | Phoenix85338 | NCT07562152 | Map |
| CA | City of Hope | Duarte91010 | NCT07562152 | Map |
| GA | Piedmont Healthcare | Atlanta30318 | NCT07562152 | Map |
| IL | City of Hope | Chicago60099 | NCT07562152 | Map |
| IL | OSF Medical Center | Peoria61603 | NCT07562152 | Map |
| MO | Missouri Cancer Associates | Columbia65201 | NCT07562152 | Map |
| NV | Comprehensive Cancer Centers | Las Vegas89169 | NCT07562152 | Map |
| NJ | Regional Cancer Care | Belleville07109 | NCT07562152 | Map |
| NY | NYU Langone Health | New York10016 | NCT07562152 | Map |
| OH | Taylor Cancer Research Center | Maumee43537 | NCT07562152 | Map |
| PA | Thomas Jefferson University | Philadelphia19107 | NCT07562152 | Map |
| TN | Sarah Cannon Research Institute | Nashville37203 | NCT07562152 | Map |
| TX | Texas Oncology - San Antonio | San Antonio78240 | NCT07562152 | Map |
| TX | Texas Oncology Gulf Coast | Webster77598 | NCT07562152 | Map |
| VA | Blue Ridge Cancer Care | Blacksburg24060 | NCT07562152 | Map |
Atebimetinib clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P3 | 1 | 1 |
Recruiting Atebimetinib clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07562152 | MAPKeeper 301Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma | P3 | Pancreatic Cancer | 510 | Jun 2026 |
Atebimetinib pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| MAPKeeper 301 | NCT07562152 | P3 | recruiting | Pancreatic Cancer | 510 | — |
All Atebimetinib trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07562152 | MAPKeeper 301 | Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma | P3 | recruiting | 510 | Immuneering Corporation | Jun 2026 |
Atebimetinib clinical trials: frequently asked questions
- How many Atebimetinib clinical trials are there?
- 1 Atebimetinib clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are Atebimetinib clinical trials recruiting in 2026?
- Yes — 1 Atebimetinib trial is actively recruiting in 2026, with 15 U.S. sites across 13 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is Atebimetinib being studied for?
- Atebimetinib is being studied for Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic, Pancreatic Cancer, Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma and 3 more. The trials are grouped by indication on this page.
- What phase is Atebimetinib in?
- Atebimetinib clinical trials span 1 Phase 3. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors Atebimetinib clinical trials?
- The lead sponsor across the most Atebimetinib trials is Immuneering Corporation. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Atebimetinibas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: